S. Lammel

Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation

U. Landmesser, M. Witkowski, U. Rauch, 2023, Biomedicines.

Quantitative Gas Exchange in Extracorporeal Membrane Oxygenation-A New Device: Accuracy, Approach-based Difficulties, and Caloric Targeting

T. Wollersheim, S. Weber-Carstens, Sarah K. Wilke, 2022, ASAIO journal.

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation

A. Dörner, B. Rauch, R. Glauben, 2021, Cells.

Cytotoxic CD8+ T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation

M. Witkowski, U. Rauch, J. Friebel, 2022, Cells.

Thrombin receptor protease-activated receptor 1 (PAR1) related cytotoxic CD8+ T cell activity is associated with atrial myopathy and pro-inflammatory immune response in early atrial fibrillation

U. Rauch, J. Friebel, K. Jakobs, 2022, European Heart Journal.